I Can sEe Left Atrial Appendage (ICELAA) Clinical Study (ICELAA)
Sponsor: Boston Scientific Corporation
A NA clinical study on Efficacy, Self and Safety Issues, this trial is completed. The trial is conducted by Boston Scientific Corporation and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Jul 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Jul 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 5 earlier versions
-
Feb 2021 — Apr 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
May 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
-
Jan 2020 — May 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
For direct contact, visit the study record on ClinicalTrials.gov .